Chicago’s Star-Studded Cures Gala
Celebrates 26 years of Gateway-Funded Groundbreaking Clinical Research Trials
CHICAGO (August 8, 2017) -- Gateway for Cancer Research founder Richard J Stephenson and Dr. Stacie J. Stephenson announce the annual Cures Gala, "Gateway to OZ," on November 18, 2017 at the Grand Ballroom at McCormick Place, 2301 South King Drive, Chicago. The Emerald City-worthy event, co-chaired and presenting sponsors Richard J Stephenson and Dr. Stacie J. Stephenson and honorary chair Jim Gordon, Founder & Managing Partner of The Edgewater Funds, will celebrate the "courage, intelligence and heart" of Gateway, a non-profit dedicated to funding transformational cancer research.
Click your heels along a magical journey beginning with a unique culinary experience followed by a special presentation of world renowned entertainment. Tickets are $1,000 per person. For sponsorship opportunities, contact email@example.com.
All proceeds from "Gateway to OZ" will help support Gateway for Cancer Research Phase I and Phase II trials across cancer types, including breast, blood and lung cancers.
Gateway's Associates Board, consisting of young professionals in the Chicago area, will host its annual Be A Hero Cocktail Reception on Friday, November 17, to kick-off the weekend's celebration
To purchase 2017 "Gateway to OZ" and Be a Hero Cocktail Reception tickets firstname.lastname@example.org.
For more information about Gateway for Cancer Research and the clinical research trials it funds, visit www.GatewayCR.org and follow the conversation online at #DemandCures.
ABOUT GATEWAY FOR CANCER RESEARCH
"Our mission instills a sense of urgency to accelerate the pace of cancer research," said Teresa Hall Bartels, president, Gateway for Cancer Research. "Our dedication to investing in novel patient-centric approaches, combined with the increasing rate of treatment advances, leads us to believe that together we can conquer cancer in our lifetime."
Gateway for Cancer Research℠ is a nonprofit 501(c)(3) organization committed to funding innovative cancer research that helps people living with cancer to feel better, live longer and conquer cancer TODAY! Thanks to generous underwriting, 99 cents of every dollar Gateway receives directly funds Phase I and Phase II cancer clinical trials at leading research institutions across the country and abroad. Since 1991, Gateway has supported more than 150 clinical trials and funded over $70 million in breakthrough cancer research. Get involved today by visiting www.GatewayCR.org, like us on Facebook at facebook.com/demandcures and join the conversation on Twitter at @DemandCures, #BeAGateway.
Current Gateway-funded clinical trials
Clinical trials funded at leading institutions worldwide
Funds one patient for one day at a Gateway-funded clinical trial